At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 24 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 45 Years to 80 Years
- Who
- All
- Number of participants
- 1,000
- Started
- 2025-02-05
- Last checked
- 2026-05
Plain English Summary
What is this study?
- • Testing a new treatment for heart failure
- • Clinical study - 1,000 participants
- • The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease
Who can take part?
- • Ages 45 Years to 80 Years
- • Diagnosed with heart failure
Where?
- • London - Richmond Pharmacology
- • London - Richmond Pharmacology
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the study will be used to monitor changes in the patient's standard of care throughout the study period and gather patient perspectives on routine diagnostic procedures and disease monitoring and feedback on the design of heart failure trials.
More detail
Patients with heart failure with mildly reduced or preserved ejection fraction will be invited to participate in this patient observational study. After providing informed consent, participants will then undergo a series of clinical assessments, and the participants' ECGs will be used to contribute to establishing an ECG library for future heart disease research. Additionally, patients' perspectives on the current standard of care clinical procedures will be gathered. Patient preferences will be gathered in relation to factors around routine clinical investigations for heart failure to better design a disease monitoring tool to include clinical and patient preferences. Also, the patients may be updated on the latest therapy options. Additionally, participants may be invited to review and provide feedback on the study design of heart failure trials under development, helping to ensure alignment with patient needs. Their input can identify potential procedure challenges and enhance the clarity of study materials, improving overall patient engagement. A follow-up call with a research physician will provide the opportunity to discuss any issues identified in the clinical baseline assessment and allow the participant to ask any additional questions.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 45 Years - 80 Years
- Who can join: All genders
Biomarkers mentioned
What the study is looking for
- ✓Male or female participants aged 45 to 80 years (inclusive) at the date of signing the agreement to take part.
- ✓Diagnosed with heart failure.
- ✓Able and willing to provide agreement to take part to participate.
Who cannot take part
- ✗Diagnostic test results positive for:
- ✗HIV-1 or HIV-2 infection
- ✗Hepatitis B or Hepatitis C infection
- ✗Any condition judged by the Investigator to pose an undue risk while participating in the trial
- ✗Diagnostic results which are inconsistent with heart failure with mildly reduced or preserved ejection fraction as...
See the full criteria
Where Is This Study? (2 UK sites)
Richmond Pharmacology
London SE1 1YR, United Kingdom
Richmond Pharmacology
London SE1 1YR, United Kingdom
How to Get in Touch
Volunteer Recruitment Team
Sponsor contactCONTACT
